Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions
Osteo Arthritis Knee
Interventions
COMBINATION_PRODUCT

PRP + HA injection

Following autologous PRP harvesting and production, 5 mL of PRP and 40 mg/2 mL of HA will be infiltrated into the knee joint affected by gonarthrosis. The combined procedure will be performed by first infiltrating the hyaluronic acid, and next, leaving the needle inserted into the joint to avoid a second needle insertion, the PRP will be infiltrated, respecting the conditions of sterility. In this way, the two products will not be mixed in the same syringe.

BIOLOGICAL

PRP injection

Following autologous PRP harvesting and production, patients randomized into control group 1 will undergo single intra-articular PRP infiltration. Five mL of PRP will be infiltrated into the knee joint affected by gonarthrosis.

DEVICE

HA injection

Patients randomized into control group 2, will undergo similar blood sampling as the PRP+ HA group and the PRP group to maintain blinding. They will then undergo intra-articular infiltration of 40 mg/ 2 ml HA into the knee with gonarthrosis.

Trial Locations (1)

40136

IRCCS Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
collaborator

University Hospital of Ferrara

OTHER

lead

Istituto Ortopedico Rizzoli

OTHER

NCT06685120 - Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis | Biotech Hunter | Biotech Hunter